Dimitri P Mikhailidis
Overview
Explore the profile of Dimitri P Mikhailidis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
909
Citations
12404
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Y, Zhong Z, Gue Y, Banach M, McDowell G, Mikhailidis D, et al.
Lancet Reg Health Eur
. 2025 Mar;
50:101245.
PMID: 40046687
[This corrects the article DOI: 10.1016/j.lanepe.2024.101182.].
2.
Chen Y, Zhong Z, Gue Y, Banach M, McDowell G, Mikhailidis D, et al.
Lancet Reg Health Eur
. 2025 Jan;
49:101182.
PMID: 39759579
Background: Insulin resistance (IR) is an important risk factor for multiple chronic diseases, increasing mortality and reducing life expectancy. The associations between emerging surrogates for IR, triglyceride-glucose index (TyG) and...
3.
Banach M, Fronczek M, Osadnik T, Gach A, Strapagiel D, Slomka M, et al.
Arch Med Sci
. 2024 Dec;
20(5):1452-1460.
PMID: 39649254
Introduction: Classical risk factors such as hypertension, hypercholesterolemia, pre-diabetes, diabetes and obesity can predict adverse cardiovascular events, but they are less prognostic in patients aged < 60 years. Polygenic risk...
4.
Jensterle M, Blinc A, Mikhailidis D, Anagnostis P, Schernthaner G, Antignani P, et al.
Curr Vasc Pharmacol
. 2024 Dec;
PMID: 39633519
No abstract available.
5.
Poredos P, Mikhailidis D, Paraskevas K, Blinc A, Antignani P, Stanek A, et al.
Int Angiol
. 2024 Nov;
43(5):541-547.
PMID: 39559843
Hypertension is a major risk factor for peripheral arterial atherosclerotic disease (PAD). Hypertension deteriorates arterial wall function and the morphology of all layers of arteries. Endothelial cell injury enhances permeability...
6.
Blinc A, Paraskevas K, Stanek A, Jawien A, Antignani P, Mansilha A, et al.
Int Angiol
. 2024 Oct;
43(4):458-467.
PMID: 39463151
Adherence to the Mediterranean diet (MeD) has been associated with a reduced incidence of peripheral arterial disease (PAD)/lower extremity arterial disease (LEAD) in observational trials and in a randomized trial....
7.
Paraskevas K, Poredos P, Stanek A, Blinc A, Jawien A, Antignani P, et al.
Int Angiol
. 2024 Sep;
43(4):450-457.
PMID: 39302145
Introduction: Dyslipidemia is an established risk factor for cardiovascular diseases. We aimed to review its role in the pathogenesis of lower extremity arterial disease (LEAD), as well as the effect...
8.
Borozan S, Vujosevic S, Mikhailidis D, Muzurovic E
Curr Vasc Pharmacol
. 2024 Aug;
PMID: 39129278
No abstract available.
9.
Poredos P, Paraskevas K, Mikhailidis D, Stanek A, Jawien A, Antignani P, et al.
Int Angiol
. 2024 Jul;
43(3):374-377.
PMID: 39045665
This article briefly discusses the risk factors for the development of lower extremity artery disease, namely smoking, diabetes mellitus, hyperlipidemia/dyslipidemia and hypertension. Each of these risk factors will be discussed...
10.
Stanek A, Mikhailidis D, Paraskevas K, Jawien A, Antignani P, Mansilha A, et al.
Int Angiol
. 2024 Jul;
43(3):367-373.
PMID: 39041784
Diabetes mellitus (DM) is a major risk factor for lower extremity arterial disease (LEAD) and about 20% of symptomatic patients with LEAD have DM. In subjects with DM, LEAD is...